CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis

Abstract Metastasis is the leading cause of death in patients with cutaneous melanoma. CRIP1 (cysteine-rich protein 1) has been reported to be associated with malignant progression of several cancers. However, the biological function and underlying mechanisms of CRIP1 in melanoma progression are lar...

Full description

Saved in:
Bibliographic Details
Main Authors: Jianqiang Wu, Lixia Chen, Peijun Wen
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-88373-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862313339322368
author Jianqiang Wu
Lixia Chen
Peijun Wen
author_facet Jianqiang Wu
Lixia Chen
Peijun Wen
author_sort Jianqiang Wu
collection DOAJ
description Abstract Metastasis is the leading cause of death in patients with cutaneous melanoma. CRIP1 (cysteine-rich protein 1) has been reported to be associated with malignant progression of several cancers. However, the biological function and underlying mechanisms of CRIP1 in melanoma progression are largely unknown. Bioinformatic prediction of CRIP1 expression in melanoma and its association with clinical parameters and prognosis of patients. Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blots (WB) were used to detect stable overexpression and knockdown of CRIP1 in melanoma cells. The function of CRIP1 in cutaneous melanoma cells was determined by in vitro functional assays. WB, immunofluorescence, OCR detection, mitochondrial DNA assay, and cytosolic ATP assay were used to determine the relationship between CRIP1 and mitochondrial biogenesis, relationship between TFAM. The expression level of CRIP1 in melanoma tissues is lower than that in normal tissues and suggests a poor prognosis for melanoma patients. Functionally, CRIP1 inhibits the proliferation, migration, and invasion of melanoma cells in vitro. Mechanistic studies revealed that CRIP1 inhibited mitochondrial biogenesis in melanoma cells, which included suppression of relative mitochondrial content, mitochondrial DNA copy number, ATP production, respiratory capacity, and expression levels of oxidative phosphorylation-related proteins. Further studies revealed that CRIP1 inhibits mitochondrial biogenesis and malignant progression in melanoma cells by suppressing the protein levels of TFAM. Our results suggest that CRIP1 inhibits the proliferation and invasive ability of cutaneous melanoma cells by suppressing TFAM-mediated mitochondrial biogenesis. Therefore, CRIP1 may be a potential therapeutic target for melanoma.
format Article
id doaj-art-86258ad9f5124c6ab2921eba90862edb
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-86258ad9f5124c6ab2921eba90862edb2025-02-09T12:35:41ZengNature PortfolioScientific Reports2045-23222025-02-0115111810.1038/s41598-025-88373-xCRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesisJianqiang Wu0Lixia Chen1Peijun Wen2Department of Dermatology, the Affiliated Panyu Central Hospital, Guangzhou Medical UniversityDepartment of Pathology, the First Affiliated Hospital, Sun Yat-Sen UniversityDepartment of Dermatology, the Affiliated Panyu Central Hospital, Guangzhou Medical UniversityAbstract Metastasis is the leading cause of death in patients with cutaneous melanoma. CRIP1 (cysteine-rich protein 1) has been reported to be associated with malignant progression of several cancers. However, the biological function and underlying mechanisms of CRIP1 in melanoma progression are largely unknown. Bioinformatic prediction of CRIP1 expression in melanoma and its association with clinical parameters and prognosis of patients. Real-time quantitative polymerase chain reaction (RT-qPCR) and Western blots (WB) were used to detect stable overexpression and knockdown of CRIP1 in melanoma cells. The function of CRIP1 in cutaneous melanoma cells was determined by in vitro functional assays. WB, immunofluorescence, OCR detection, mitochondrial DNA assay, and cytosolic ATP assay were used to determine the relationship between CRIP1 and mitochondrial biogenesis, relationship between TFAM. The expression level of CRIP1 in melanoma tissues is lower than that in normal tissues and suggests a poor prognosis for melanoma patients. Functionally, CRIP1 inhibits the proliferation, migration, and invasion of melanoma cells in vitro. Mechanistic studies revealed that CRIP1 inhibited mitochondrial biogenesis in melanoma cells, which included suppression of relative mitochondrial content, mitochondrial DNA copy number, ATP production, respiratory capacity, and expression levels of oxidative phosphorylation-related proteins. Further studies revealed that CRIP1 inhibits mitochondrial biogenesis and malignant progression in melanoma cells by suppressing the protein levels of TFAM. Our results suggest that CRIP1 inhibits the proliferation and invasive ability of cutaneous melanoma cells by suppressing TFAM-mediated mitochondrial biogenesis. Therefore, CRIP1 may be a potential therapeutic target for melanoma.https://doi.org/10.1038/s41598-025-88373-xMelanomaCRIP1TFAMMitochondrial biogenesis
spellingShingle Jianqiang Wu
Lixia Chen
Peijun Wen
CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
Scientific Reports
Melanoma
CRIP1
TFAM
Mitochondrial biogenesis
title CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
title_full CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
title_fullStr CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
title_full_unstemmed CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
title_short CRIP1 inhibits cutaneous melanoma progression through TFAM-mediated mitochondrial biogenesis
title_sort crip1 inhibits cutaneous melanoma progression through tfam mediated mitochondrial biogenesis
topic Melanoma
CRIP1
TFAM
Mitochondrial biogenesis
url https://doi.org/10.1038/s41598-025-88373-x
work_keys_str_mv AT jianqiangwu crip1inhibitscutaneousmelanomaprogressionthroughtfammediatedmitochondrialbiogenesis
AT lixiachen crip1inhibitscutaneousmelanomaprogressionthroughtfammediatedmitochondrialbiogenesis
AT peijunwen crip1inhibitscutaneousmelanomaprogressionthroughtfammediatedmitochondrialbiogenesis